OBVAMconcussion-related convergence insufficiency (CONC-CI)CONC-CINCT05262361
…difference was observed for NPC, PFV or CISS (p=1.0).Conclusion OBVAM therapy is effective in improving the NPC, PFV and symptoms in …
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 274 of 2459ARNIheart failure-relatedquadruple therapyβ-blockerheart failure with reduced ejection fractionARBACEi
…e therapy at discharge in 2022. Prescription rates for ACEi/ARB/ARNI (67%), beta-blockers (89%), MRAs (40%), and SGLT2 inhibitors (4…
EazyplexChlamydia trachomatisNeisseria gonorrhoeaeGeneXpertsyndromic managementNG
…ed, respectively. All results had specificity ≥98.5%.Conclusion Eazyplex was highly specific but moderately sensitive in detecting NG an…
atopic dermatitisvitiligopsoriasisDAK-Gesundheit
…m 5.3% to 17.9% across definitions. In matched comparisons with atopic dermatitis, only a few and inconsistent differences were observed. In cont…
Chronic obstructive pulmonary diseasePulmonary rehabilitationCOPDEmbasePubMedCochrane Central Register of Controlled TrialsWeb of ScienceCINAHL
…Introduction Chronic obstructive pulmonary disease (COPD) affects approximately 480 million individuals globally a…
opioid use disorderneedle and syringe programmesCochrane LibraryPWUDMEDLINEnaloxonemedication treatmentsexually transmitted and blood-borne infection careWeb of ScienceEMBASE+1 more
…(21%), naloxone distribution (19%) and medication treatment for opioid use disorder (19%). Pharmacy staff were integrated into multidisciplinary te…
ACSCNational Health Service
…The exposure was ID status, and the outcomes were (1) unplanned ACSC hospital admission, (2) death with an ACSC condition listed as …
University of PaduaUniversity Medical Centre LjubljanaSLEUMCLJUniPDaPS/PTLupus anticoagulantLACOrgentec DiagnostikaINOVA+1 more
…2011 to 2025 at the University Medical Centre Ljubljana and the University of Padua. IgG and IgM anticardiolipin (aCL), anti-βglycoprotein I (anti-…
Proliferative LNSLEsystemic lupus erythematosuslupus nephritisproliferative lupus nephritistertiary referral hospital
…y; p=0.012), and all cases occurred at proteinuria >300 mg/day. Proliferative LN was associated with higher clinical SLEDAI scores, higher anti–…
srSLEobe-cellupus nephritisNCT06333483SLESLE-related
…00M doseConclusions In these preliminary findings of obe-cel in srSLE, obe-cel demonstrated a favourable safety profile and clinical …
SLECLEhydroxychloroquine
… healthy controls (n=9) were analysed for comparison.Results In SLE patients, the percentage of mitochondria-positive mature erythr…
Systemic Lupus Erythematosusairway diseasesILDOrganizing Pneumonitispleural diseasesPulmonary diseasesInterstitial lung diseases (ILD)SLEPD
…Objectives Pulmonary diseases (PD) in Systemic Lupus Erythematosus (SLE) have received little attention despite it being prevalent…